These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

357 related items for PubMed ID: 3950467

  • 1. Role of inflammation in the lung disease of systemic sclerosis: comparison with idiopathic pulmonary fibrosis.
    Owens GR, Paradis IL, Gryzan S, Medsger TA, Follansbee WP, Klein HA, Dauber JH.
    J Lab Clin Med; 1986 Mar; 107(3):253-60. PubMed ID: 3950467
    [Abstract] [Full Text] [Related]

  • 2. [Pulmonary involvement in sclerodermia].
    Paone G, Di Michele L, Mattia P, Tonnarini R, Lucifora V, Fiorucci F.
    Minerva Med; 1994 Jun; 85(6):293-300. PubMed ID: 8084431
    [Abstract] [Full Text] [Related]

  • 3. Lung inflammation in scleroderma: clinical, radiographic, physiologic and cytopathological features.
    Edelson JD, Hyland RH, Ramsden M, Chamberlain DW, Kortan P, Meindok HO, Klein MH, Braude AC, Lee P, Rebuck AS.
    J Rheumatol; 1985 Oct; 12(5):957-63. PubMed ID: 4087272
    [Abstract] [Full Text] [Related]

  • 4. Lung transplantation in scleroderma compared with idiopathic pulmonary fibrosis and idiopathic pulmonary arterial hypertension.
    Schachna L, Medsger TA, Dauber JH, Wigley FM, Braunstein NA, White B, Steen VD, Conte JV, Yang SC, McCurry KR, Borja MC, Plaskon DE, Orens JB, Gelber AC.
    Arthritis Rheum; 2006 Dec; 54(12):3954-61. PubMed ID: 17133609
    [Abstract] [Full Text] [Related]

  • 5. Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung Study.
    Khanna D, Clements PJ, Furst DE, Chon Y, Elashoff R, Roth MD, Sterz MG, Chung J, FitzGerald JD, Seibold JR, Varga J, Theodore A, Wigley FM, Silver RM, Steen VD, Mayes MD, Connolly MK, Fessler BJ, Rothfield NF, Mubarak K, Molitor J, Tashkin DP, Scleroderma Lung Study Group.
    Arthritis Rheum; 2005 Feb; 52(2):592-600. PubMed ID: 15692967
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Lymphocyte populations in bronchoalveolar lavage fluid in various interstitial lung diseases].
    Müller S, Kramer H, Bergmann KC, Wiesner B, Grollmuss H, Unger U, Christ R, Eckert H.
    Z Erkr Atmungsorgane; 1984 Feb; 163(2):140-5. PubMed ID: 6506803
    [Abstract] [Full Text] [Related]

  • 16. [Relation between 67-gallium scintigraphy and bronchoalveolar lavage--differential cell count and superoxide anion liberation--in patients with systemic scleroderma and systemic lupus erythematosus].
    Witt C, Apostoloff E, Müller GM, Buchali K, Hiepe F, Brenke A, Romberg B, Winsel K.
    Pneumologie; 1992 Jan; 46(1):20-5. PubMed ID: 1312240
    [Abstract] [Full Text] [Related]

  • 17. Lymphocyte phenotypes in bronchoalveolar lavage and lung tissue in sarcoidosis and idiopathic pulmonary fibrosis.
    Paradis IL, Dauber JH, Rabin BS.
    Am Rev Respir Dis; 1986 May; 133(5):855-60. PubMed ID: 3486613
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.